Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
09/05/2025
Chardan Capital: Maintains buy rating on Cognition Therapeutics (CGTX.US), adjusted from buy to buy rating, target price adjusted from 8.00 dollars to 4.00 dollars.
Latest
2 m ago
Navarro: The US-UK agreement will boost exports of beef, dairy products, corn, and ethanol.
3 m ago
Navarro: The UK agreement provides us with a template for how we will move forward.
4 m ago
Boeing narrowed its gains, rising nearly 5% at one point during trading.
4 m ago
Boeing narrowed its gains during intraday trading, briefly rising nearly 5%.
5 m ago
UBS: Maintains Quidel Ortho (QDEL.US) rating, adjusting from neutral to neutral rating, with target price adjusted from $45.00 to $29.00.
See all latest